Organon & Co. (OGN)
13.76
0.00 (0.00%)
USD |
NYSE |
Oct 16, 16:00
13.76
0.00 (0.00%)
After-Hours: 20:00
Organon Free Cash Flow (Quarterly) : 31.00M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 31.00M |
| March 31, 2026 | 178.00M |
| December 31, 2025 | 200.00M |
| September 30, 2025 | 149.00M |
| June 30, 2025 | 181.00M |
| March 31, 2025 | -22.00M |
| December 31, 2024 | 290.00M |
| September 30, 2024 | 88.00M |
| June 30, 2024 | 285.00M |
| March 31, 2024 | 30.00M |
| December 31, 2023 | 318.00M |
| September 30, 2023 | 206.00M |
| June 30, 2023 | -44.00M |
| Date | Value |
|---|---|
| March 31, 2023 | 60.00M |
| December 31, 2022 | 326.00M |
| September 30, 2022 | 102.00M |
| June 30, 2022 | 67.00M |
| March 31, 2022 | 60.00M |
| December 31, 2021 | 235.00M |
| September 30, 2021 | -183.00M |
| June 30, 2021 | 1.413B |
| March 31, 2021 | 697.00M |
| December 31, 2020 | 266.00M |
| September 30, 2020 | 284.00M |
| June 30, 2020 | 756.00M |
| March 31, 2020 | 626.00M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Merck & Co., Inc. | 4.477B |
| Viatris, Inc. | 328.00M |
| Pfizer Inc. | 302.00M |
| Pacira Biosciences, Inc. | 56.12M |
| Bristol Myers Squibb Co. | 3.088B |